EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Vergleichsstudie

Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial

M Wei, Y Chai, H Shen, M Du, X Zhou, T Liu, X Yang, S Li, J Sun, Y Ge

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.4.13488 ↗

At a glance

Randomisierte kontrollierte Studie in Acta Gastro Enterologica Belgica, 2024. Written by M Wei and 9 co-authors. Institution: Department of Traditional Chinese Medicine, Jiangsu Provincial Hospital, Nanjing, China. Major MEDLINE topics: Domperidone, Dyspepsia, Flavonoids. Cited 2 times so far (Crossref); 42 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The clinical management of functional dyspepsia (FD) is challenging. This study evaluated the efficacy and safety of Aurantii Fructus Immaturus flavonoid (AFIF) tablets vs. domperidone for FD.

Methods

This multicenter, randomized, double-blind, doubledummy, positive-controlled trial recruited FD patients, who were randomized 1:1 to the AFIF (AFIF and domperidone placebo) and domperidone (domperidone and AFIF placebo) groups. The primary endpoint was the rate of disappearance of all four FD symptoms (postprandial feeling of fullness, early satiety, upper abdominal pain, and upper abdominal burning sensation) after 4 treatment weeks.

Results

Totally 120 and 119 patients were included in the AFIF and domperidone groups, respectively. The rates of disappearance of all four symptoms after 4 treatment weeks were 28.33% and 31.93% in the AFIF and domperidone groups, respectively (p=0.5748). The rate of disappearance of all four symptoms 4 weeks after treatment discontinuation was significantly higher in the AFIF (21.05%) compared with the domperidone group (4.39%, p=0.0002). The gastric emptying rates 2h after a meal were significantly increased in both AFIF (7.58%, p

Subjects

MeSH terms (MEDLINE)

DomperidoneDyspepsiaFlavonoidsHumansDouble-Blind MethodMaleFemaleAdultMiddle AgedTreatment OutcomeTabletsDrugs, Chinese HerbalCitrus

Author keywords

disappearance of symptomsgastric emptyingtraditional Chinese medicine

Substances

DomperidoneFlavonoidsTabletsDrugs, Chinese Herbal

Authors and institutions

  • Department of Traditional Chinese Medicine, Jiangsu Provincial Hospital, Nanjing, China.
  • GCP center of Jiangsu Province Hospital, Nanjing, China.
  • Department of Gastroenterology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China.
  • Department of Nuclear Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China.
  • Department of Liver, Spleen and Stomach Diseases, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Department of Hepatobiliary, Spleen and Stomach, Affiliated Hospital of Henan Academy of Traditional Chinese Medicine, Zhengzhou, China.

Cite

APA

Wei, M., Chai, Y., Shen, H., Du, M., Zhou, X., Liu, T., Yang, X., Li, S., Sun, J., & Ge, Y. (2024). Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.4.13488

Vancouver

Wei M, Chai Y, Shen H, Du M, Zhou X, Liu T, et al. Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.4.13488

BibTeX
@article{Wei2024,
  author = {Wei, M and Chai, Y and Shen, H and Du, M and Zhou, X and Liu, T and Yang, X and Li, S and Sun, J and Ge, Y},
  title = {Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.4.13488}
}
Start for free →